The global AI chipsets market is anticipated to grow at a CAGR of 40.5% during the forecast period. The growing adoption of AI chipsets across the healthcare industry is expected to propel the growth of the market during the forecast period. Key players and researchers are also involved in launching new devices to cater to the unmet requirement of the healthcare industry. For instance, in August 2022, Researchers at the University of Chicago developed a wearable computing chip, which can analyze a patient’s health data in real-time using AI. The device known as a neuromorphic computing chip uses semiconductors and electrochemical transistors to collect data from biosensors touching the skin. The researchers installed AI algorithms within the chip to efficiently analyze relevant patterns within the data.
Browse the full report description of “Artificial Intelligence (AI) Chipsets Market Size, Share & Trends Analysis Report by Hardware (Processor, Memory, and Network), by Technology (Machine Learning (ML), Natural Language Processing (NLP), Context-Aware Computing, and Computer Vision), and by End-Users (BFSI, Government, Retail, Healthcare, Cybersecurity, and Others) Forecast Period (2022-2028)” at https://www.omrglobal.com/industry-reports/artificial-intelligence-ai-chipsets-market
In February 2022, MyHealthcare Technologies Pvt. Ltd. launched AI-enabled MyHealthcare Enterprise Application (MHEA) for hospitals and healthcare institutes. The application enables clinicians and hospital teams to manage complete patient care and hospital operation, through a task-based healthcare information management system. The application is designed to drive operational and process efficiencies across the provider network, and assist with the complete digitization of the clinical, administrative, and procurement process. The company used process automation and AI to bring users relevant information and enable them to complete all tasks from a single screen.
Apart from this, in November 2021, Royal Philips provides health technology launched AI-powered MR 5300 1.5T system, which has received 510(k) clearance from the FDA. It is designed to speed up MR exams, streamline workflows, optimize diagnostic quality, and ensure the efficiency and sustainability of radiology operations. Additionally, it simplifies and automates complex clinical and operational tasks with helium-free MR operations, driving consistent quality and sustainability for outpatient clinics and MR departments. This will drive the AI chipset market during the forecast period.
Market Coverage
• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
o By Hardware
o By Technology
o By End-Users
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- including Tenstorrent Inc, SambaNova Systems Inc, Samsung Electronics Co., Ltd., Micron Technology, Inc., Microsoft Corp., Amazon Web Services, Advanced Micro Devices, Inc., and others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Artificial Intelligence (AI) Chipsets Market Report Segment
By Hardware
By Technology
By End-Users
Global Artificial Intelligence (AI) Chipsets Market Report Segment by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/artificial-intelligence-ai-chipsets-market